|
|
|
|
|
by hanspragt
2987 days ago
|
|
It sort of depends on what you define as success. The goal was never to "cure" the cancer, rather, to shrink the tumor. I hesitate to assign an exact percentage to the effectiveness since there are so many factors to consider, but I remember Keytruda being reported to shrink tumors in less than a third of patients who took it. |
|
> “Chemotherapy has limitations. Immunotherapy has the ability to cure. I lead the Yale lung team. We have patients on these immunotherapies alive more than eight years.”